Candesartan cilexetil impurity E is a chemical compound identified as a process-related impurity of the active pharmaceutical ingredient candesartan cilexetil. It is a structurally related benzimidazole derivative carrying ester and ether functionalities, used as a reference standard in pharmaceutical quality control.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Candesartan cilexetil impurity E?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Trityl candesartan cilexetil
pharmaceutical intermediate
Candesartan cilexetil
pharmaceutical raw material
Dactolisib
pharmaceutical raw material
Flurbiprofen axetil
pharmaceutical raw material
(R)-4-((3R,5S,6R,8S,9S,10S,13R,14S,17R)-6-ethyl-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
pharmaceutical raw material
Enzalutamide
pharmaceutical raw material
1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(1-ethyltetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
HKUZPIFWPFYKBZ-UHFFFAOYSA-N
CCN1C(=NN=N1)C2=CC=CC=C2C3=CC=C(C=C3)CN4C5=C(C=CC=C5N=C4OCC)C(=O)OC(C)OC(=O)OC6CCCCC6
Sourcing Candesartan cilexetil impurity E?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.